Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality

BACKGROUND: The WHO has recently published updated guidance for national strategic planning for TB. To address the TB epidemic comprehensively, it is necessary to conduct an epidemiological review as part of the situation analysis in the national strategic plan. METHODS: A descriptive epidemiologica...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Commiesie, D. Stijnberg, J. van den Boogaard, F. Gopie, S. Vreden, G. de Vries
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-01-01
Series:IJTLD Open
Subjects:
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000001/art00007
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592369097113600
author E. Commiesie
D. Stijnberg
J. van den Boogaard
F. Gopie
S. Vreden
G. de Vries
author_facet E. Commiesie
D. Stijnberg
J. van den Boogaard
F. Gopie
S. Vreden
G. de Vries
author_sort E. Commiesie
collection DOAJ
description BACKGROUND: The WHO has recently published updated guidance for national strategic planning for TB. To address the TB epidemic comprehensively, it is necessary to conduct an epidemiological review as part of the situation analysis in the national strategic plan. METHODS: A descriptive epidemiological study was conducted using data from the national TB register for the period of 2010–2020. Simple frequencies were calculated for demographic and clinical variables. Trends in TB notification rates for the period 2010–2020 were also calculated. RESULTS: TB notification rates between 2011 (24.3/100,000) and 2019 (23.9/100,000) remained almost the same. The HIV status was known for 97.1% of TB cases, 22.7% of whom had HIV co-infection; 10.9% of patients with detected Mycobacterium tuberculosis were also resistant to rifampicin. Case fatality rate for all cases was 13.0%. Of the identified contacts, 66% were screened; 28.3–47.5% of those with TB infection started treatment, 63.3–75.9% of whom completed treatment. CONCLUSION: The review identified the following areas of concern: no decline in TB rates, high proportion of TB-HIV co-infection, high rate of resistance to rifampicin, high case-fatality rates and suboptimal contact investigation care cascade . The review was used to inform interventions and key actions to reduce TB morbidity and mortality in Suriname.
format Article
id doaj-art-9d273ac47426427fab0aa85a8a34ac19
institution Kabale University
issn 3005-7590
language English
publishDate 2024-01-01
publisher International Union Against Tuberculosis and Lung Disease (The Union)
record_format Article
series IJTLD Open
spelling doaj-art-9d273ac47426427fab0aa85a8a34ac192025-01-21T09:59:34ZengInternational Union Against Tuberculosis and Lung Disease (The Union)IJTLD Open3005-75902024-01-0111344010.5588/ijtldopen.23.05357Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortalityE. Commiesie0D. Stijnberg1J. van den Boogaard2F. Gopie3S. Vreden4G. de Vries5National Tuberculosis Programme, Paramaribo,National Tuberculosis Programme, Paramaribo,National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands;Anton de Kom University, Paramaribo, Suriname;Anton de Kom University, Paramaribo, Suriname;Anton de Kom University, Paramaribo, Suriname;BACKGROUND: The WHO has recently published updated guidance for national strategic planning for TB. To address the TB epidemic comprehensively, it is necessary to conduct an epidemiological review as part of the situation analysis in the national strategic plan. METHODS: A descriptive epidemiological study was conducted using data from the national TB register for the period of 2010–2020. Simple frequencies were calculated for demographic and clinical variables. Trends in TB notification rates for the period 2010–2020 were also calculated. RESULTS: TB notification rates between 2011 (24.3/100,000) and 2019 (23.9/100,000) remained almost the same. The HIV status was known for 97.1% of TB cases, 22.7% of whom had HIV co-infection; 10.9% of patients with detected Mycobacterium tuberculosis were also resistant to rifampicin. Case fatality rate for all cases was 13.0%. Of the identified contacts, 66% were screened; 28.3–47.5% of those with TB infection started treatment, 63.3–75.9% of whom completed treatment. CONCLUSION: The review identified the following areas of concern: no decline in TB rates, high proportion of TB-HIV co-infection, high rate of resistance to rifampicin, high case-fatality rates and suboptimal contact investigation care cascade . The review was used to inform interventions and key actions to reduce TB morbidity and mortality in Suriname.https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000001/art00007tuberculosisepidemiologysituational analysishivnational strategic plan
spellingShingle E. Commiesie
D. Stijnberg
J. van den Boogaard
F. Gopie
S. Vreden
G. de Vries
Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
IJTLD Open
tuberculosis
epidemiology
situational analysis
hiv
national strategic plan
title Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
title_full Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
title_fullStr Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
title_full_unstemmed Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
title_short Key drivers of the TB epidemic in Suriname and priority actions to reduce incidence and mortality
title_sort key drivers of the tb epidemic in suriname and priority actions to reduce incidence and mortality
topic tuberculosis
epidemiology
situational analysis
hiv
national strategic plan
url https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000001/art00007
work_keys_str_mv AT ecommiesie keydriversofthetbepidemicinsurinameandpriorityactionstoreduceincidenceandmortality
AT dstijnberg keydriversofthetbepidemicinsurinameandpriorityactionstoreduceincidenceandmortality
AT jvandenboogaard keydriversofthetbepidemicinsurinameandpriorityactionstoreduceincidenceandmortality
AT fgopie keydriversofthetbepidemicinsurinameandpriorityactionstoreduceincidenceandmortality
AT svreden keydriversofthetbepidemicinsurinameandpriorityactionstoreduceincidenceandmortality
AT gdevries keydriversofthetbepidemicinsurinameandpriorityactionstoreduceincidenceandmortality